Tag archive for ‘Orphan Drug Status’
Gil Tanenbaum On Monday, December 22nd, 2014

Can-Fite Treats First Patient with New Cancer Drug

Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, treated the first patient with its CF 102 in a Phase More...

Can-Fite is part of Israel startup nation
Gil Tanenbaum On Wednesday, October 1st, 2014

Can-Fite BioPharma Liver Drug Gets US Patent

Israel’s Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, has received a patent in the US for its More...

Wordpress site Developed by Fixing WordPress Problems